Market Performance Snapshot
At 10:51 AM Central European time on Thursday, 22 September 2026, the shares of Hebei Jianxin Chemical Co., Ltd. (300107.SZ) closed unchanged, trading flat at a price of CNY 7.80. Over the preceding 24 hours the stock exhibited no net gain or loss, reflecting a period of consolidation after a modest uptick of 12.82 % since the end of August.
Key quantitative metrics for the day include:
- Share price: CNY 7.80
- Shares outstanding: 578.6 million
- Market capitalisation: CNY 4.40 billion
- Turnover: CNY 352.1 million
- Volume traded in the last 24 h: CNY 352.1 million worth of shares
- 200‑day simple moving average: CNY 6.49
- 52‑week high/low: CNY 10.75 (26 Feb 2026) / CNY 5.34 (09 Jul 2026)
These figures illustrate a company that remains firmly anchored within its industry while navigating the broader volatility of the Shenzhen market.
Comparative Peer Performance
While Hebei Jianxin Chemical’s price remained flat, its contemporaries posted a similar lack of movement. The following table summarizes the 24‑hour performance of selected peers:
| Company | Ticker | Price (CNY) | Market Cap (CNY) | P/E Ratio |
|---|---|---|---|---|
| Wushang | 000501.SZ | 6.93 | 5.20 bn | 35.45 |
| Yunnan Nantian Electronics | 000948.SZ | 13.95 | 5.20 bn | 96.72 |
| Yimikang Tech | 300249.SZ | 11.70 | 5.20 bn | 138.63 |
| Markor Home Furnishin | 600337.SS | 3.61 | 5.30 bn | – |
| Jiangsu Canlon Building Ma | 300715.SZ | 13.98 | 5.20 bn | 862.05 |
Although most peers also traded flat, Yunnan Nantian Electronics stands out with a relatively high price‑to‑earnings ratio and a recent quarterly improvement, signalling a cautious yet positive outlook for its expanding product portfolio in smart‑device and automotive segments.
Company Overview
Hebei Jianxin Chemical Co., Ltd. is a research‑intensive materials manufacturer headquartered in Cangzhou, China. The firm specialises in the development, production, and marketing of dye intermediates and a broad array of chemical feedstocks. Its product catalogue includes, among others:
- Metanilic acid, aniline‑2,5‑disulfonic acid monosodium salt
- 3‑diethylaminophenol, m‑aminophenol, sulfanilic acid
- ODB‑1, ODB‑2, R‑04, EBA, BBA, MMD, DPA, DBSP, BON, n‑butyl bromide
These chemicals serve as critical intermediates across diverse industries such as pharmaceuticals, fibre manufacturing, pesticides, dyestuffs, and health care. Additionally, the company supplies alkylating agents, solvents, and extracting agents for rare‑earth separation and organic synthesis. Its downstream offerings include curing agents, epoxy resins, engineering plastics, and polysulfone amides, while its polysulfonamide fibres act as monomers for high‑performance plastics.
The company’s global footprint is significant; its products are exported to Europe, the United States, Japan, Korea, Taiwan, and Hong Kong. Hebei Jianxin Chemical has maintained a stable presence on the Shenzhen Stock Exchange since its initial public offering on 20 August 2010 and continues to leverage its R&D capabilities to meet evolving market demands.
Market Context
The flat trading of Hebei Jianxin Chemical and its peers reflects a period of equilibrium within the Chinese market, where investors weigh recent earnings reports against macroeconomic signals. While the company’s 200‑day moving average of CNY 6.49 remains below its current trading price, the sustained upward trend of 12.82 % since August suggests underlying confidence in its business model. The 52‑week high of CNY 10.75, achieved earlier this year, serves as a potential resistance point, whereas the 52‑week low of CNY 5.34 provides a floor for short‑term speculation.
In contrast, the high valuation multiples of several peers—particularly Jiangsu Canlon Building Ma’s P/E of 862.05—highlight a market segment in which investors demand premium pricing for niche or rapidly expanding product lines. Hebei Jianxin Chemical’s more modest P/E ratio, while not disclosed here, aligns with a focus on steady growth rather than rapid expansion.
Outlook
Analysts anticipate that Hebei Jianxin Chemical will continue to benefit from its diversified product base and established export network. The company’s emphasis on R&D, combined with its ability to produce key intermediates for high‑value sectors such as pharmaceuticals and advanced composites, positions it favorably against competitors that rely primarily on commodity pricing.
Should the firm sustain its current trajectory of operational stability and modest earnings growth, its share price may gradually approach the 52‑week high, contingent upon broader market confidence and commodity price dynamics. Investors will likely monitor the company’s quarterly reports for any signs of accelerated product development, new international contracts, or shifts in raw‑material cost structures that could influence its valuation metrics.
